Wilshire Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WILSHIRE PHARMS INC, and what generic and branded alternatives to WILSHIRE PHARMS INC drugs are available?
WILSHIRE PHARMS INC has eleven approved drugs.
Drugs and US Patents for Wilshire Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wilshire Pharms Inc | DEOXYCHOLIC ACID | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 212296-001 | Apr 2, 2021 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Wilshire Pharms Inc | FORMOTEROL FUMARATE | formoterol fumarate | SOLUTION;INHALATION | 215621-001 | Dec 13, 2022 | AN | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Wilshire Pharms Inc | ICATIBANT ACETATE | icatibant acetate | INJECTABLE;SUBCUTANEOUS | 211501-001 | Sep 1, 2020 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.